血管紧张素Ⅱ抑制剂应用于慢性肝病患者的药代动力学研究概况
出处
《广西医学》
CAS
2003年第5期738-740,共3页
Guangxi Medical Journal
参考文献11
-
1[1]Pidlich J, Cichini GM, Reinisch W, et al. Angiotensin-converting enzyme inhibition in cirrhotic patients-pharmacokinetics of ramipril. Acta Med Austriaca 1997;24(1):5
-
2[2]Ford NF,Lasseter KC,Van Harken DR,et al. Single-dose and steady-state pharmacokinetics of fosinopril in patients with hepatic impairment. J Clin Pharmacol 1995 ;35(2): 145
-
3[3]Loguercio C, Piscopo P, Guerriero C, et al. Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis. Clin Ther 1994; 145(12) :475
-
4[4]Furuta S, Kiyosawa K, Higuchi M, et al. Pharmacokinetics of temocapil - an ACE inhibitor with preferential biliary exeretion, in patients with impaired liver function. Eur J Clin Pharmacol 1993 ;44(4) :383
-
5[5]Gross V, Treher E, Haag K, et al. Angiotensin converting enzyme (ACE)-inhibition in cirrhosis, pharmacokinetics and dynamics of the ACE-inhibitor cilazaprill(R031-2848) Hepatol 1993; 17(1):40
-
6[6]Krahenbuhl S, Grass P. Surve A, et al. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease. Eur J Clin Pharmacol 1993;45(3) :247
-
7[7]Thiollet M, Funck-Brentano C, Grange JD, et al. The pharmacokinetics of perindopril in patients with liver cirrhosis. Br J Clin Pharmacol 1992;33(3):326
-
8[8]Bumier M, Roch-Ramel F, Brunner HR, et al. Renal effects of angiotensin Ⅱ receptor blockade in normotansive sub Ⅱ jects.Kidney Int 1996;(49):1787
-
9[9]Matsusaka T, Hymes J, Ichikawa I, et al. Angiotensin in progressive renel diseases: theory and practice [editorial] J Am Soc Nephrol 1996;7:2025
-
10[10]Marino MR, Langenbacher KM, Raymond RH, et al. Pharmacokinetics and pharmacodynamics of irbessartan in patients with hepatic cirrbcsis. J Clin Pharmacol 1998;38(4) :34.7
-
1宋怀宇,孙成刚,朱菊人.血管紧张素Ⅱ抑制剂防治慢肝、肝硬化的临床研究进展[J].临床肝胆病杂志,2003,19(4):200-201. 被引量：3
-
2唐志立,唐贤芳,曾友志,欧树凡,董玉龙,唐光清.老年喘息型支气管炎口服氨茶碱的药代动力学[J].华西药学杂志,1995,10(4):200-201.
-
3孙文庆,苗爱华.谈头孢三嗪在胆道感染中的应用价值[J].中华医药学杂志,2003,2(5):72-72.
-
4鲁海婷.浅谈老年人的合理用药[J].中华综合医学,2001,2(6):559-559.
-
5柳达,文静,等.老年心血管病安全用药注意的问题[J].中华医学写作杂志,2002,9(11):865-866.
-
6沈再朗.抗菌药物在肝功能减退时的临床应用[J].中国药业,1999,8(3):54-54.
-
7沈建颖,宿燕岗,王克强,葛均波.Chymase在血管紧张素Ⅱ生成中的作用[J].心血管病学进展,2004,25(2):118-121. 被引量：1
-
8陈达卫.阿奇霉素联合头孢噻肟钠治疗下呼吸道感染的临床观察[J].中国基层医药,2012,19(6):929-930. 被引量：3
-
9肖永祺,伍卫.血管紧张素Ⅱ受体拮抗剂在高血压病治疗中的进展及评价[J].心血管病学进展,2002,23(4):221-223. 被引量：25
-
10郑广才.多肽、蛋白质药物鼻腔给药系统的研究进展[J].中国药事,2007,21(7):521-524. 被引量：2
